Skip to main content
DONGWHA PHARM.CO.,LTD logo

DONGWHA PHARM.CO.,LTD — Investor Relations & Filings

Ticker · 000020 ISIN · KR7000020008 KO Manufacturing
Filings indexed 223 across all filing types
Latest filing 2025-03-26 Declaration of Voting R…
Country KR South Korea
Listing KO 000020

About DONGWHA PHARM.CO.,LTD

https://www.dong-wha.co.kr

Dongwha Pharm is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a diverse range of healthcare products. Its portfolio includes ethical (prescription) pharmaceuticals, over-the-counter (OTC) drugs, medical devices, quasi-drugs, health functional foods, cosmetics, and beverages. The company's research and development efforts focus on various therapeutic areas, including alimentary and cardiovascular systems. Dongwha Pharm actively pursues innovation through its drug pipeline, clinical trials, and strategic investments in emerging fields like digital therapeutics.

Recent filings

Filing Released Lang Actions
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for Dongwha Pharm. It details the outcomes of the AGM, including the approval of financial statements, dividend declarations, and the election of directors and audit committee members. This document is a formal report of the voting results and resolutions passed during the meeting, which falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-03-26 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding the change of the company's Representative Director (CEO). It lists the names of the outgoing and incoming directors, the reason for the change (reappointment and new appointment), the effective date, and provides biographical details for the new appointees. This content directly matches the definition for 'Board/Management Information' (MANG).
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). This falls under the category of board management and changes in corporate governance structure, specifically categorized as Board/Management Information (MANG).
2025-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (insiders) and their special related parties, including specific transaction details like gifts (증여) and sales. This falls under the category of Major Shareholding Notification.
2025-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a change in share ownership by a company executive (Yoon Do-joon) due to a gift of shares. This type of filing is a standard regulatory requirement for insider transactions, which falls under the 'Director's Dealing' category.
2025-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the shareholding changes of an executive (Yoon In-ho) of Dong-A Socio Holdings (Dong-A Pharmaceutical). This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it documents insider transactions and changes in ownership status by company directors/executives.
2025-03-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.